Physician profile
Ismael P Lopez
NPI 1417033994
$24,471.64
in general payments reported to CMS, 2019-2025
26 companies · $4,283 in 2025
The $4,283 reported for 2025 was more than what 93% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $936 · 2021: $489 · 2022: $371 · 2023: $4,368 · 2024: $13K · 2025: $4,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $20K · Food and Beverage: $1,383 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $20,000.00 |
| Food and Beverage | $1,383.44 |
| Travel and Lodging | $652.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,822.34 | 2020-2025 | Da Vinci Surgical System |
| Gynesonics, INC. | $532.44 | 2020 | |
| Pfizer INC. | $367.69 | 2019-2023 | |
| Abbvie INC. | $309.42 | 2019-2022 | |
| Therapeuticsmd, INC. | $213.40 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $200.98 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $159.08 | 2019-2023 | |
| Coopersurgical, INC. | $150.19 | 2019-2022 | |
| Myovant Sciences INC. | $95.69 | 2022 | |
| Avion Pharmaceuticals | $84.08 | 2019-2022 | |
| Medical Device Business Services, INC. | $70.48 | 2024 | Ethicon |
| Organon LLC | $67.09 | 2024-2025 | Nexplanon |
| Aspira Women'S Health INC | $58.15 | 2022-2024 | Ova1 |
| Covidien Lp | $41.41 | 2019 | |
| Merck Sharp & Dohme LLC | $40.20 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $38.78 | 2019 | |
| Minerva Surgical, INC | $37.27 | 2023-2025 | |
| Davol INC. | $31.28 | 2021 | |
| Ethicon US, LLC | $29.13 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $27.52 | 2025 | Exparel |
| Millicent US INC | $19.47 | 2021 | |
| Exeltis, USA INC. | $18.94 | 2023 | Slynd |
| Avanos Medical | $16.99 | 2019 | |
| Medtronic USA, INC. | $15.10 | 2019 | |
| Coloplast Corp | $13.31 | 2021 | |
| Agile Therapeutics, INC. | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ismael Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.